The Extent of Papillary Muscle Approximation Affects Mortality and Durability of Mitral Valve Repair for Ischemic Mitral Regurgitation

Overview

Journal J Cardiothorac Surg

Publisher Biomed Central

Specialties Cardiology & Vascular Diseases
General Surgery
Pulmonary Medicine

Date 2014 Jun 5

PMID 24893928

Citations 9

Authors

Satoru Wakasa

Suguru Kubota

Yasushige Shingu

Tomonori Ooka

Tsuyoshi Tachibana

Yoshiro Matsui

Affiliations

Soon will be listed here.

Abstract

Background: Since reduction annuloplasty alone for ischemic mitral regurgitation (MR) cannot prevent late recurrence of MR or improve survival for those with left ventricular (LV) dysfunction, and the surgical approach to this etiology is still controversial, we conducted a study to assess the efficacy of the additional papillary muscle approximation (PMA) procedure for ischemic MR by comparing the different subtypes of PMA.

Methods: We studied 45 patients who underwent mitral annuloplasty and papillary muscle approximation (PMA) for ischemic MR between 2003 and 2012. Papillary muscles were approximated entirely (cPMA: complete PMA, n = 32) through an LV incision or partially from the tips to mid-parts (iPMA: incomplete PMA, n = 13) through the mitral and aortic valves. Twenty-three patients with cPMA also underwent LV plasty (LVP). We assessed the outcomes after PMA by comparing cPMA and iPMA.

Results: The baseline MR grade, NYHA class, LV end-diastolic diameter, and LV ejection fraction (LVEF) were 2.8 ± 1.0, 3.2 ± 0.6, 67 ± 6 mm, and 30 ± 10%, respectively. There were no significant differences in these parameters among those with iPMA, cPMA/LVP-, and cPMA/LVP+, though iPMA patients had better LVEF than others. Three patients died before discharge and 12 died during the follow-up. Recurrence of grade 2+ and 3+ MR occurred in 8 and 2 patients, respectively. Reoperation for recurrent MR was performed only for the 2 patients with recurrence of grade 3+ MR. The cPMA was associated with lower mortality (log-rank P = 0.020) and a lower rate of recurrence of MR ≥2+ (log-rank P = 0.005) than iPMA. In contrast, there were no significant differences in the mortality (log-rank P = 0.45) and rate of recurrence (log-rank P = 0.98) between those with cPMA/LVP- and cPMA/LVP+. The 4-year survival rate and rate of freedom from recurrence of MR ≥2+ were 83% and 85% for those with cPMA, repectively. In contrast, the rates were 48% and 48% for those with iPMA, respectively.

Conclusions: Complete PMA could be associated with lower postoperative mortality and higher durability of mitral valve repair for ischemic MR.

Citing Articles

Comparing surgical techniques and results of secondary ischemic mitral regurgitation: a state-of-the-art literature review.

Nappi F Ann Transl Med. 2024; 12(5):91.

PMID: 39507449 PMC: 11534758. DOI: 10.21037/atm-24-39.

Commentary: What do we still have to learn from surgery?.

Belluschi I, Glauber M, Miceli A JTCVS Open. 2022; 7:109-110.

PMID: 36003714 PMC: 9390765. DOI: 10.1016/j.xjon.2021.06.014.

Commentary: The mitral valve and the left ventricle in functional mitral regurgitation: The puppet and the puppeteer.

Xu D, Padala M JTCVS Open. 2022; 5:63-65.

PMID: 36003163 PMC: 9390187. DOI: 10.1016/j.xjon.2020.11.011.

Papillary Muscle Approximation Reduces Systolic Tethering Forces and Improves Mitral Valve Closure in the Repair of Functional Mitral Regurgitation.

Zhan-Moodie S, Xu D, Suresh K, He Q, Onohara D, Kalra K JTCVS Open. 2022; 7:91-104.

PMID: 35299626 PMC: 8924981. DOI: 10.1016/j.xjon.2021.04.008.

Secondary mitral regurgitation repair techniques and outcomes: Subannular repair techniques in secondary mitral regurgitation type IIIb.

Pausch J, Girdauskas E, Conradi L, Reichenspurner H JTCVS Tech. 2022; 10:92-97.

PMID: 34977710 PMC: 8691802. DOI: 10.1016/j.xjtc.2021.09.019.

References

Crabtree T, Bailey M, Moon M, Munfakh N, Pasque M, Lawton J . Recurrent mitral regurgitation and risk factors for early and late mortality after mitral valve repair for functional ischemic mitral regurgitation. Ann Thorac Surg. 2008; 85(5):1537-42. DOI: 10.1016/j.athoracsur.2008.01.079. View

Matsui Y, Suto Y, Shimura S, Fukada Y, Naito Y, Yasuda K . Impact of papillary muscles approximation on the adequacy of mitral coaptation in functional mitral regurgitation due to dilated cardiomyopathy. Ann Thorac Cardiovasc Surg. 2005; 11(3):164-71. View

Matsui Y, Fukada Y, Suto Y, Yamauchi H, Luo B, Miyama M . Overlapping cardiac volume reduction operation. J Thorac Cardiovasc Surg. 2002; 124(2):395-7. DOI: 10.1067/mtc.2002.123616. View

Levine R, Schwammenthal E . Ischemic mitral regurgitation on the threshold of a solution: from paradoxes to unifying concepts. Circulation. 2005; 112(5):745-58. DOI: 10.1161/CIRCULATIONAHA.104.486720. View

Frater R . The effects on cordal and leaflet stiffness of severe apical, posterior, and outward papillary displacement in advanced ventricular mechanism heart failure and mitral insufficiency. J Heart Valve Dis. 2012; 20(6):608-18. View

Jensen H, Jensen M, Smerup M, Vind-Kezunovic S, Ringgaard S, Andersen N . Impact of papillary muscle relocation as adjunct procedure to mitral ring annuloplasty in functional ischemic mitral regurgitation. Circulation. 2009; 120(11 Suppl):S92-8. DOI: 10.1161/CIRCULATIONAHA.108.817833. View

Kumanohoso T, Otsuji Y, Yoshifuku S, Matsukida K, Koriyama C, Kisanuki A . Mechanism of higher incidence of ischemic mitral regurgitation in patients with inferior myocardial infarction: quantitative analysis of left ventricular and mitral valve geometry in 103 patients with prior myocardial infarction. J Thorac Cardiovasc Surg. 2003; 125(1):135-43. DOI: 10.1067/mtc.2003.78. View

Grigioni F, Enriquez-Sarano M, Zehr K, Bailey K, Tajik A . Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment. Circulation. 2001; 103(13):1759-64. DOI: 10.1161/01.cir.103.13.1759. View

Kubota K, Otsuji Y, Ueno T, Koriyama C, Levine R, Sakata R . Functional mitral stenosis after surgical annuloplasty for ischemic mitral regurgitation: importance of subvalvular tethering in the mechanism and dynamic deterioration during exertion. J Thorac Cardiovasc Surg. 2010; 140(3):617-23. PMC: 2972671. DOI: 10.1016/j.jtcvs.2009.11.003. View

10.

Rama A, Nappi F, Praschker B, Gandjbakhch I . Papillary muscle approximation for ischemic mitral valve regurgitation. J Card Surg. 2008; 23(6):733-5. DOI: 10.1111/j.1540-8191.2008.00641.x. View

11.

Wu A, Aaronson K, Bolling S, Pagani F, Welch K, Koelling T . Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction. J Am Coll Cardiol. 2005; 45(3):381-7. DOI: 10.1016/j.jacc.2004.09.073. View

12.

Menicanti L, Di Donato M, Frigiola A, Buckberg G, Santambrogio C, Ranucci M . Ischemic mitral regurgitation: intraventricular papillary muscle imbrication without mitral ring during left ventricular restoration. J Thorac Cardiovasc Surg. 2002; 123(6):1041-50. DOI: 10.1067/mtc.2002.121677. View

13.

Deja M, Grayburn P, Sun B, Rao V, She L, Krejca M . Influence of mitral regurgitation repair on survival in the surgical treatment for ischemic heart failure trial. Circulation. 2012; 125(21):2639-48. PMC: 3776601. DOI: 10.1161/CIRCULATIONAHA.111.072256. View

14.

Kuwahara E, Otsuji Y, Iguro Y, Ueno T, Zhu F, Mizukami N . Mechanism of recurrent/persistent ischemic/functional mitral regurgitation in the chronic phase after surgical annuloplasty: importance of augmented posterior leaflet tethering. Circulation. 2006; 114(1 Suppl):I529-34. DOI: 10.1161/CIRCULATIONAHA.105.000729. View

15.

Matsunaga A, Tahta S, Duran C . Failure of reduction annuloplasty for functional ischemic mitral regurgitation. J Heart Valve Dis. 2004; 13(3):390-7. View

16.

De Bonis M, Ferrara D, Taramasso M, Calabrese M, Verzini A, Buzzatti N . Mitral replacement or repair for functional mitral regurgitation in dilated and ischemic cardiomyopathy: is it really the same?. Ann Thorac Surg. 2012; 94(1):44-51. DOI: 10.1016/j.athoracsur.2012.01.047. View

17.

Mandegar M, Roshanali F, Yousefnia M, Marzban M . Papillary muscle approximation combined with ventriculoplasty in patients with ischemic cardiomyopathy and functional mitral regurgitation: effects on mitral valve and LV shape. Interact Cardiovasc Thorac Surg. 2007; 5(2):81-4. DOI: 10.1510/icvts.2005.118430. View

18.

Zoghbi W, Enriquez-Sarano M, Foster E, Grayburn P, Kraft C, Levine R . Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr. 2003; 16(7):777-802. DOI: 10.1016/S0894-7317(03)00335-3. View

19.

Jorapur V, Voudouris A, Lucariello R . Quantification of annular dilatation and papillary muscle separation in functional mitral regurgitation: role of anterior mitral leaflet length as reference. Echocardiography. 2005; 22(6):465-72. DOI: 10.1111/j.1540-8175.2005.04045.x. View

20.

Bach D, Bolling S . Early improvement in congestive heart failure after correction of secondary mitral regurgitation in end-stage cardiomyopathy. Am Heart J. 1995; 129(6):1165-70. DOI: 10.1016/0002-8703(95)90399-2. View